Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot ...

The LGBTQ+ community and its allies gathered for the 34th Annual AIDS Walk Music Festival and 5k Run on Sept. 27, raising $1 ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...

Gilead offers a meaningful upside opportunity should it execute on increasing revenue growth to the low-to-middle single ...

The initiative is part of a broader campaign to ensure a healthy and stigma-free working environment within the justice ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...